Pharmaceutical manufacturing and distribution of medicines and related products in India.
Annual revenue $378,505 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Grecian

Grecian is a company. The company has 1 employees as of August 24, 2024. Grecian offers products and services including Tablets and Injections.

  • Employees 1 as on 24 Aug, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Grecian Private Limited
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $378.5 K (USD)
    -11.34
    as on Mar 31, 2023
  • Net Profit
    $434.71 (USD)
    -65.2
    as on Mar 31, 2023
  • EBITDA
    $22.97 K (USD)
    712.47
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Aug 24, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Grecian

Grecian offers a comprehensive portfolio of products and services, including Tablets and Injections.

Product name locked
Category locked
Primary

Tablets are manufactured by Grecian for various therapeutic uses, including treatments in cardiology and anti-diabetic categories.

Product name locked
Category locked
Locked

Injections are produced by Grecian for critical care and oncology applications, ensuring availability in both Indian and international markets.

Funding Insights of Grecian

Premium access

Detailed funding history for Grecian

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Grecian

Investments
Premium access

Investment portfolio details for Grecian

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Grecian

Premium access

Detailed financials for Grecian

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Grecian Comparisons

Grecian Primary company
Description
Pharmaceutical manufacturing and distribution of medicines a...
Location
-
Founded Year
-
Annual Revenue
$378.5 K (USD)
Net Profit
$434.71 (USD)
EBITDA
$22.97 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Grecian

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Grecian

Premium access

Detailed competitors of Grecian

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Grecian

Premium access

Complete news archive for Grecian

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Grecian

As of Aug 24, 2024, the latest employee count at Grecian is 1.

Annual revenue of Grecian is $378.5K as on Mar 31, 2023.

Grecian is recognized as a pharmaceutical company that provides a variety of products such as tablets, capsules, and injections, aimed at therapeutic areas like cardiology and oncology. Quality products are manufactured with competitive pricing and attractive packaging to serve community needs in India and internationally. A vision is held by Grecian to become a leading entity through innovative business models and adherence to values like social responsibility and sustainability. Operations are supported by certifications and a focus on research and development, ensuring products meet global standards while contributing to societal well-being and environmental nurturing.

Grecian offers Tablets and Injections.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available